This mechanism consists on the production of a neurotoxic anti-sense transcript (ATXN2-AS), which was detected in the post-mortem cerebellum and cortex of SCA2 patients, a transgenic mouse model and some cell lines (111). This evidence concerns the gene ATXN2 and spinocerebellar ataxia type 2.